6C42.2Z

ICD-11 MMS 2026-01

Synthetic cannabinoid dependence, unspecified

Exclusions from above levels

  • 6C42.0 – Episode of harmful use of synthetic cannabinoids
  • 6C42.1 – Harmful pattern of use of synthetic cannabinoids
  • 6C41 – Disorders due to use of cannabis
Show allHide
  • QE62 – Uncomplicated bereavement
  • QE84 – Acute stress reaction

Sibling codes

  • 6C42.20 – Synthetic cannabinoid dependence, current use
  • 6C42.21 – Synthetic cannabinoid dependence, early full remission
  • 6C42.22 – Synthetic cannabinoid dependence, sustained partial remission
  • 6C42.23 – Synthetic cannabinoid dependence, sustained full remission
  • 6C42.2Y – Other specified synthetic cannabinoid dependence

Foundation entity

Synthetic cannabinoid dependence – http://id.who.int/icd/entity/686500513

Allowed postcoordination axes

Part of: 6C42.2: Synthetic cannabinoid dependence › 6C42: Disorders due to use of synthetic cannabinoids › 06: Mental, behavioural or neurodevelopmental disorders